Markus W. Wendeler

Novartis (Switzerland)

Papers

1

Total Citations

26

H-Index

1

About

Markus W. Wendeler is a leading figure in bioprocess analytics, with a focused expertise in the automation and validation of immunoassays for biopharmaceutical quality control. His most impactful work centers on the development of flexible, fully automated ELISA platforms designed to detect critical impurities such as host cell proteins and Protein A in therapeutic protein production. In his landmark 2012 paper, Wendeler detailed a groundbreaking system that not only streamlined detection but also underwent rigorous validation to meet industry standards, directly addressing a major bottleneck in bioprocessing. This contribution, which has garnered 26 citations, is widely recognized for enhancing the reliability and throughput of impurity testing, a key step in ensuring patient safety. Wendeler’s achievements underscore his role in bridging the gap between laboratory innovation and practical, regulatory-compliant manufacturing, making his work essential reading for researchers and engineers in the biopharmaceutical field.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals
26 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago